Went back and read through some of the recent announcements and saw the endometriosis POC was mentioned as due in the Sept quarter.
I know it's still bit early but seems to coincide? It's too early for Jannsen outcome and all other PromarkerD commercialization announcements didn't require a trading halt, so it has to be something relating to a discovery or fundamental change in the company.
Source: ASX Release30 July 2019
Went back and read through some of the recent announcements and...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.010(0.89%) |
Mkt cap ! $147.9M | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.15 | $1.12 | $30.28K | 26.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1200 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 5395 | 3 |
View Market Depth
| Last trade - 12.40pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
0.010 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| $1.15 | $1.15 | $1.13 | 9302 | ||
| Last updated 12.11pm 19/04/2024 ? | |||||
| PIQ (ASX) Chart |